These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32043666)

  • 1. The impact of hidradenitis suppurativa on general health is higher than that of hypertension, congestive heart failure, type 2 diabetes, myocardial infarction and depression.
    Sampogna F; Fania L; Mazzanti C; Pallotta S; Panebianco A; Mastroeni S; Didona B; Abeni D
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e386-e388. PubMed ID: 32043666
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of cardiovascular disorders in hidradenitis suppurativa patients: a large-scale, propensity-matched global retrospective cohort study.
    Krajewski PK; Matusiak Ł; Ständer S; Thaçi D; Szepietowski JC; Zirpel H
    Int J Dermatol; 2024 Jun; 63(6):799-805. PubMed ID: 38644522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidradenitis suppurativa and major adverse cardiac events: A systematic review and meta-analysis.
    Joseph Bailey AM; Oi-Yee Li H; Tan MG; Kirchhof MG
    J Am Acad Dermatol; 2021 Mar; 84(3):844-848. PubMed ID: 33038472
    [No Abstract]   [Full Text] [Related]  

  • 4. Additional follow-up from the ABCD trial in patients with type 2 diabetes and hypertension.
    Schrier RW; Estacio RO
    N Engl J Med; 2000 Dec; 343(26):1969. PubMed ID: 11186674
    [No Abstract]   [Full Text] [Related]  

  • 5. Hidradenitis suppurativa is associated with myocardial infarction, but not stroke or peripheral arterial disease of the lower extremities.
    Miller IM; Ahlehoff O; Zarchi K; Rytgaard H; Mogensen UB; Ellervik C; Jemec GB
    Br J Dermatol; 2018 Mar; 178(3):790-791. PubMed ID: 28914960
    [No Abstract]   [Full Text] [Related]  

  • 6. Differences between diabetic and non-diabetic hypertensive patients with first acute non-ST elevation myocardial infarction and predictors of in-hospital complications.
    Colivicchi F; Mettimano M; Genovesi-Ebert A; Schinzari F; Iantorno M; Melina G; Santini M; Cardillo C; Melina D
    J Cardiovasc Med (Hagerstown); 2008 Mar; 9(3):267-72. PubMed ID: 18301144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hidradenitis suppurativa and diabetes mellitus: A systematic review and meta-analysis.
    Bui TL; Silva-Hirschberg C; Torres J; Armstrong AW
    J Am Acad Dermatol; 2018 Feb; 78(2):395-402. PubMed ID: 29056237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes mellitus in a cohort of Finnish patients with hidradenitis suppurativa.
    Kluger N; Nuutinen P; Lybeck E; Ruohoalho T; Salava A
    J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):e98-e100. PubMed ID: 31596976
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosing Hidradenitis Suppurativa.
    Revuz JE; Jemec GB
    Dermatol Clin; 2016 Jan; 34(1):1-5. PubMed ID: 26617351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence and risk factors of depression in patients with hidradenitis suppurativa.
    Ravn Jørgensen AH; Holm JG; Yao Y; Ring HC; Thomsen SF
    J Am Acad Dermatol; 2020 Nov; 83(5):e377-e379. PubMed ID: 32707258
    [No Abstract]   [Full Text] [Related]  

  • 11. Hospital admissions for cardiovascular complications of people with or without diabetes, Victoria, 2004-2016.
    Kiburg KV; MacIsaac AI; Wilson A; Sundararajan V; MacIsaac RJ
    Med J Aust; 2021 Jul; 215(2):85-86. PubMed ID: 34028039
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of hidradenitis suppurativa on quality of life is worse than inflammatory bowel disease and myocardial infarction.
    Mortimore AM; Bullen A; McMeniman EK
    Australas J Dermatol; 2022 Nov; 63(4):505-508. PubMed ID: 35932467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidradenitis suppurativa and diabetes mellitus: updated systematic review and adjusted meta-analysis.
    Phan K; Charlton O; Smith SD
    Clin Exp Dermatol; 2019 Jun; 44(4):e126-e132. PubMed ID: 30730068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of cardiovascular comorbidities in hidradenitis suppurativa: A nationwide, population-based, cohort study in Taiwan.
    Hung CT; Chiang CP; Chung CH; Tsao CH; Chien WC; Wang WM
    J Dermatol; 2019 Oct; 46(10):867-873. PubMed ID: 31389066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. At 180 days hidradenitis suppurativa readmission rate is comparable to heart failure: Analysis of the nationwide readmissions database.
    Edigin E; Kaul S; Eseaton PO; Albrecht J
    J Am Acad Dermatol; 2022 Jul; 87(1):188-192. PubMed ID: 34314742
    [No Abstract]   [Full Text] [Related]  

  • 16. Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients.
    Shalom G; Freud T; Harman-Boehm I; Polishchuk I; Cohen AD
    Br J Dermatol; 2015 Aug; 173(2):464-70. PubMed ID: 25760289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hidradenitis suppurativa, a rare skin disease.
    Khattak JI; Zahid U
    J Pak Med Assoc; 2020 Feb; 70(2):348-350. PubMed ID: 32063633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving an acute myocardial infarction.
    Melchior T; Gadsbøll N; Hildebrandt P; Køber L; Torp-Pedersen C
    Diabet Med; 1996 May; 13(5):450-6. PubMed ID: 8737027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidradenitis Suppurativa in Down Syndrome: A Case Series.
    Hamadah I; Haider M; Chisti M; Binamer Y
    Pediatr Dermatol; 2017 Jul; 34(4):461-464. PubMed ID: 28636122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of metabolic syndrome and hidradenitis suppurativa.
    Miller IM; Ellervik C; Vinding GR; Zarchi K; Ibler KS; Knudsen KM; Jemec GB
    JAMA Dermatol; 2014 Dec; 150(12):1273-80. PubMed ID: 25229996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.